Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 4Recruiting 4Terminated 3Active not recruiting 3Not yet recruiting 2Completed 2Available 1Approved for marketing 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Lymphoid 130Other hematologic neoplasm 86Plasma cell 49Gastrointestinal 35CNS 31Head & Neck 30Gynecologic 28Genitourinary 21Thoracic 20Sarcoma 12Dermatologic 11Breast 10Myeloid 6Other solid neoplasm 4Endocrine 4NET 2Classical hematology 1

Conditions

Neuroendocrine Tumors 111Pheochromocytoma 34Carcinoma, Neuroendocrine 31Pituitary Neoplasms 27Paraganglioma 27Thyroid Cancer, Papillary 26Adrenocortical Carcinoma 21Neoplasms 19Gastro-enteropancreatic neuroendocrine tumor 19Thyroid Neoplasms 17Adrenal Gland Neoplasms 16Stomach Neoplasms 14Pancreatic Neoplasms 14Multiple Endocrine Neoplasia Type 1 14Carcinoid Tumor 13Sarcoma 12Prostatic Neoplasms 12Lung Neoplasms 12Thyroid Carcinoma, Anaplastic 11Colorectal Neoplasms 11Breast Neoplasms 11Adenoma, Islet Cell 11Neuroblastoma 10Neoplasm Metastasis 10Carcinoma, Hepatocellular 10Brain Neoplasms 10Small Cell Lung Carcinoma 9Ovarian Neoplasms 9Meningioma 9Esophageal Neoplasms 9

Interventions

olaparib 1lutetium Lu 177 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Recurrence × Endocrine × Clear all
NCT06607692 2026-04-14

LUPARPED

Fundación de investigación HM

Phase 1/2 Recruiting
25 enrolled
CNSEndocrineNETSarcoma

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT00599092 2026-03-23

Pituitary Tumor Surveillance: Pathogenic Correlation

Cedars-Sinai Medical Center

Recruiting
1,250 enrolled
Endocrine

Pituitary Neoplasms, Recurrence

NCT04907643 2026-02-20

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Cedars-Sinai Medical Center

Phase NA Recruiting
360 enrolled
EndocrineGastrointestinalNET

Cancer Pain, Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Stomach Neoplasms, Neuroendocrine Tumors, Visceral Pain

NCT05962892 2024-01-30

A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma

Beijing Friendship Hospital

Recruiting
600 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡